Pharmaceuticals, Biotechnology and Life Sciences
Pfizer, which was considering splitting itself for more than two years, said on Monday it would not do so, prompting shareholders to expect more deals that could bolster its roster of new medicines.
Verona Pharma #VRP appoints Vikas Sinha to the Board as a Non-Executive Director
The study, which will be conducted in up to 70 healthy individuals, aims to evaluate the tolerability of KarXT compared to xanomeline alone.
Dechra, an international specialist veterinary pharmaceuticals company, has received approval from the U.S. Food and Drug Administration (FDA) for a generic antibiotic.
Redx CFO steps down, the company searches new one
David Evans, Non-executive Chairman, has stepped down from the Board with immediate effect.
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
“Second quarter financial performance was in-line with expectations.” – Olivier Brandicourt, Sanofi CEO
Faron and Abzena in cancer medicine Clevegen manufacture deal
PureTech Health has introduced new members to its Scientific Advisory Board